197 related articles for article (PubMed ID: 8826929)
21. Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore.
Yong MH; Hwang WS; Knight LA; Fung W; Chan MY; Seow WT; Chui CH
Singapore Med J; 2009 Nov; 50(11):1090-4. PubMed ID: 19960166
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F
Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190
[TBL] [Abstract][Full Text] [Related]
23. Chromosome imbalances and alterations of AURKA and MYCN genes in children with neuroblastoma.
Inandiklioğlu N; Yilmaz S; Demirhan O; Erdoğan S; Tanyeli A
Asian Pac J Cancer Prev; 2012; 13(11):5391-7. PubMed ID: 23317189
[TBL] [Abstract][Full Text] [Related]
24. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Med Pediatr Oncol; 2003 Jul; 41(1):30-5. PubMed ID: 12764740
[TBL] [Abstract][Full Text] [Related]
25. MYCN gain and MYCN amplification in a stage 4S neuroblastoma.
Noguera R; Cañete A; Pellín A; Ruiz A; Tasso M; Navarro S; Castel V; Llombart-Bosch A
Cancer Genet Cytogenet; 2003 Jan; 140(2):157-61. PubMed ID: 12645655
[TBL] [Abstract][Full Text] [Related]
26. Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH): an alternative and practical method.
Bhargava R; Oppenheimer O; Gerald W; Jhanwar SC; Chen B
Diagn Mol Pathol; 2005 Jun; 14(2):72-6. PubMed ID: 15905689
[TBL] [Abstract][Full Text] [Related]
27. MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.
Spitz R; Hero B; Skowron M; Ernestus K; Berthold F
Eur J Cancer; 2004 Dec; 40(18):2753-9. PubMed ID: 15571958
[TBL] [Abstract][Full Text] [Related]
28. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group.
Lastowska M; Nacheva E; McGuckin A; Curtis A; Grace C; Pearson A; Bown N
Genes Chromosomes Cancer; 1997 Mar; 18(3):162-9. PubMed ID: 9071568
[TBL] [Abstract][Full Text] [Related]
29. Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma: First Report in Korean Population.
Lim H; Son MH; Hyun JK; Cho HW; Ju HY; Lee JW; Yoo KH; Sung KW; Koo HH
J Korean Med Sci; 2020 Apr; 35(14):e82. PubMed ID: 32281311
[TBL] [Abstract][Full Text] [Related]
30. The genetic and clinical significance of MYCN gain as detected by FISH in neuroblastoma.
Souzaki R; Tajiri T; Teshiba R; Higashi M; Kinoshita Y; Tanaka S; Taguchi T
Pediatr Surg Int; 2011 Mar; 27(3):231-6. PubMed ID: 21046119
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
[TBL] [Abstract][Full Text] [Related]
32. Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study.
Mathew P; Valentine MB; Bowman LC; Rowe ST; Nash MB; Valentine VA; Cohn SL; Castleberry RP; Brodeur GM; Look AT
Neoplasia; 2001; 3(2):105-9. PubMed ID: 11420745
[TBL] [Abstract][Full Text] [Related]
33. Comparative genomic hybridization analysis of human neuroblastomas: detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines.
Van Roy N; Jauch A; Van Gele M; Laureys G; Versteeg R; De Paepe A; Cremer T; Speleman F
Cancer Genet Cytogenet; 1997 Sep; 97(2):135-42. PubMed ID: 9283597
[TBL] [Abstract][Full Text] [Related]
34. Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas.
Ambros PF; Ambros IM; Kerbl R; Luegmayr A; Rumpler S; Ladenstein R; Amann G; Kovar H; Horcher E; De Bernardi B; Michon J; Gadner H
Med Pediatr Oncol; 2001 Jan; 36(1):1-4. PubMed ID: 11464855
[TBL] [Abstract][Full Text] [Related]
35. Rearrangement in the coding region of the MYCN gene in a subset of amplicons in a case of neuroblastoma with MYCN amplification.
Chen B; Jhanwar SC; Ladanyi M
Diagn Mol Pathol; 2001 Jun; 10(2):100-4. PubMed ID: 11385318
[TBL] [Abstract][Full Text] [Related]
36. MYCN gene amplification. Identification of cell populations containing double minutes and homogeneously staining regions in neuroblastoma tumors.
Yoshimoto M; Caminada De Toledo SR; Monteiro Caran EM; de Seixas MT; de Martino Lee ML; de Campos Vieira Abib S; Vianna SM; Schettini ST; Anderson Duffles Andrade J
Am J Pathol; 1999 Nov; 155(5):1439-43. PubMed ID: 10550298
[TBL] [Abstract][Full Text] [Related]
37. [Methods of detection and prognostic significance of genetic material increase of the short arm of chromosome 2 and a deletion of the short arm of chromosome 1 in patients with neuroblastoma].
Druĭ AE; Tsaur GA; Shorikov EV; Popov AM; Plekhanova OM; Typonogov SN; Savel'ev LI; Tsvirenko SV; Fechina LG
Vopr Onkol; 2013; 59(5):591-8. PubMed ID: 24260886
[TBL] [Abstract][Full Text] [Related]
38. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B
Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
[TBL] [Abstract][Full Text] [Related]
39. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.
Plantaz D; Mohapatra G; Matthay KK; Pellarin M; Seeger RC; Feuerstein BG
Am J Pathol; 1997 Jan; 150(1):81-9. PubMed ID: 9006325
[TBL] [Abstract][Full Text] [Related]
40. Highly sensitive analysis for N-myc amplification in neuroblastoma based on fluorescence in situ hybridization.
Tajiri T; Shono K; Fujii Y; Noguchi S; Kinoshita Y; Tsuneyoshi M; Suita S
J Pediatr Surg; 1999 Nov; 34(11):1615-9. PubMed ID: 10591554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]